Ashfield/Huntsworth to launch $200 million term loan on Tuesday

By Sara Rosenberg

New York, Feb. 14 – Ashfield/Huntsworth is set to hold a lender call at 10 a.m. ET on Tuesday to launch a fungible $200 million add-on term loan due 2028, according to a market source.

JPMorgan Chase Bank, NatWest, ING, Bank of Ireland, Barclays, Jefferies LLC and RBC Capital Markets are the arrangers on the deal.

Pricing on the add-on term loan is Libor plus 425 basis points with a 0.5% Libor floor.

The add-on term loan is talked with an original issue discount of 99 to 99.5, the source said.

The add-on term loan has 101 soft call protection until August.

Commitments are due at 5 p.m. ET on Feb. 22, the source added.

Proceeds will be used to fund the acquisition of Research Partnership and for general corporate purposes.

Ashfield/Huntsworth, previously known as UDG Healthcare, is a provider of medical communications, marketing, advisory and packaging services to pharma and biotech clients.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.